Mertowska P, Smolak K, Mertowski S, Grywalska E
Int J Mol Sci. 2023; 24(12).
PMID: 37373262
PMC: 10298684.
DOI: 10.3390/ijms241210115.
Magvan B, Kloeble A, Ptok J, Hoffmann D, Habermann D, Gantumur A
Front Med (Lausanne). 2023; 10:1108543.
PMID: 37035318
PMC: 10077969.
DOI: 10.3389/fmed.2023.1108543.
McKay L, Thomas J, Albalawi W, Fattaccioli A, Dieu M, Ruggiero A
Front Immunol. 2022; 13:831695.
PMID: 35371105
PMC: 8964954.
DOI: 10.3389/fimmu.2022.831695.
Yao Y, Liu M, Zang F, Yue M, Xia X, Feng Y
BMJ Open. 2018; 8(4):e019406.
PMID: 29654010
PMC: 5898346.
DOI: 10.1136/bmjopen-2017-019406.
Zaily D, Marlen C, Santiago D, Gillian M, Carmen V, Zurina C
Curr Ther Res Clin Exp. 2017; 85:20-28.
PMID: 29158855
PMC: 5681293.
DOI: 10.1016/j.curtheres.2017.04.006.
Innate and adaptive immunity shape circulating HCV strains.
Gaudieri S, Lucas M
Nat Genet. 2017; 49(5):657-658.
PMID: 28442794
DOI: 10.1038/ng.3856.
Type III Interferons in Hepatitis C Virus Infection.
Boisvert M, Shoukry N
Front Immunol. 2017; 7:628.
PMID: 28066437
PMC: 5179541.
DOI: 10.3389/fimmu.2016.00628.
IFN-λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection.
Depla M, Pelletier S, Bedard N, Brunaud C, Bruneau J, Shoukry N
Immun Inflamm Dis. 2016; 4(3):376-88.
PMID: 27621819
PMC: 5004291.
DOI: 10.1002/iid3.122.
Host-virus interactions in hepatitis B and hepatitis C infection.
Yoshio S, Kanto T
J Gastroenterol. 2016; 51(5):409-20.
PMID: 26894594
DOI: 10.1007/s00535-016-1183-3.
Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population.
Carapito R, Poustchi H, Kwemou M, Untrau M, Sharifi A, Merat S
Genes Immun. 2015; 16(8):514-8.
PMID: 26378651
DOI: 10.1038/gene.2015.38.
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins.
Bellanti F, Lauletta G, Villani R, Lipsi M, Natalicchio M, Sansonno D
Medicine (Baltimore). 2015; 94(35):e1409.
PMID: 26334898
PMC: 4616511.
DOI: 10.1097/MD.0000000000001409.
The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.
Sarvari J, Moattari A, Pirbonyeh N, Moini M, Hosseini S
J Clin Lab Anal. 2015; 30(4):301-7.
PMID: 25990657
PMC: 6806688.
DOI: 10.1002/jcla.21855.
Influence of host resistance on viral adaptation: hepatitis C virus as a case study.
Plauzolles A, Lucas M, Gaudieri S
Infect Drug Resist. 2015; 8:63-74.
PMID: 25897250
PMC: 4396509.
DOI: 10.2147/IDR.S49891.
Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making.
Puri C
J Clin Exp Hepatol. 2015; 1(1):27-33.
PMID: 25755307
PMC: 3940297.
DOI: 10.1016/S0973-6883(11)60115-1.
HLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors.
Xiong H, Huang J, Rong X, Zhang M, Huang K, Xu R
Intervirology. 2015; 58(2):80-7.
PMID: 25677350
PMC: 4394015.
DOI: 10.1159/000369209.
Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.
Verstrepen B, Boonstra A, Koopman G
World J Hepatol. 2015; 7(1):53-69.
PMID: 25624997
PMC: 4295194.
DOI: 10.4254/wjh.v7.i1.53.
Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study.
Huang P, Dong L, Lu X, Zhang Y, Chen H, Wang J
BMC Infect Dis. 2014; 14:716.
PMID: 25528575
PMC: 4279674.
DOI: 10.1186/s12879-014-0716-8.
Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines.
John M, Gaudieri S
Front Microbiol. 2014; 5:514.
PMID: 25352836
PMC: 4195390.
DOI: 10.3389/fmicb.2014.00514.
Single nucleotide polymorphisms of toll-like receptor 7 in hepatitis C virus infection patients from a high-risk chinese population.
Xue X, Gong J, Tang S, Gao C, Wang J, Cai L
Inflammation. 2014; 38(1):142-51.
PMID: 25218653
DOI: 10.1007/s10753-014-0016-x.
Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients.
Yilmaz A, Alagozlu H, Ozdemir O, Arici S
Hepat Mon. 2014; 14(7):e11283.
PMID: 25067937
PMC: 4101423.
DOI: 10.5812/hepatmon.11283.